Haematologists were aware and excited about our drug for multiple myeloma - hailing it as the ‘revolution’ and ‘Rolls Royce’.
The stunning efficacy data spoke for itself. The challenge was to communicate the key efficacy data as well as the patient benefits. It was mandatory to use the launch campaign and its visual elements to communicate the core.
Working closely with the local countries, we identified a need to communicate the patient benefits by animating the stunning efficacy data.
We created an immersive experience where delegates engaged with the brand through integrated activities and tactics that brought to life the scientific and emotive reasons to believe in the brand.
You have done such an amazing job breathing life into patients whose lives are so impacted by multiple myeloma
EUROPEAN PRODUCT MANAGER
The landscape of healthcare has changed. So have we.